1-4 of 4
Wu Zhuolin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BTK Inhibitor Synergizes with CD19-Targeted Chimeric Antigen Receptor-T Cells in Patients with Relapsed or Refractory B-Cell Lymphoma: An Open-Label Pragmatic Clinical Trial

Wenjing Luo, Yinqiang Zhang, Chenggong Li, Jia Xu, Wu Zhuolin, Xindi Wang, Yun Kang, Danying Liao, Haiming Kou, Wei Xie, Wei Xiong, Jun Deng, Yu Hu, Heng Mei
Journal: Blood
Blood (2024) 144 (Supplement 1): 6546.
https://doi.org/10.1182/blood-2024-205304
Published: 2024
Journal Articles

Prior Antibiotic Exposure Correlates with Unfavorable Efficacy and Prognosis of B-NHL after CAR-T Cell Therapy

Jia Xu, Wenjing Luo, Chenggong Li, Yinqiang Zhang, Xindi Wang, Jiachen Liu, Wu Zhuolin, Zhongpei Huang, Yun Kang, Qiaolin Liu, Zhihan Chen, Heng Mei
Journal: Blood
Blood (2024) 144 (Supplement 1): 7158.
https://doi.org/10.1182/blood-2024-209107
Published: 2024
Journal Articles

All-Trans Retinoic Acid Enhances CS1-BCMA Dual-Target CAR-T Cells in Multiple Myeloma

Yinqiang Zhang, Wu Zhuolin, Wenjing Luo, Chenggong Li, Heng Mei
Journal: Blood
Blood (2024) 144 (Supplement 1): 2052.
https://doi.org/10.1182/blood-2024-205044
Published: 2024
Journal Articles

Selinexor Reduces the Immunosuppressive Properties of Macrophages and Synergizes with CD19 CAR-T Cells Against B-Cell Lymphoma

Wenjing Luo, Jia Xu, Chenggong Li, Lu Tang, Yingying Li, Xindi Wang, Wu Zhuolin, Yinqiang Zhang, Yu Hu, Heng Mei
Journal: Blood
Blood (2024) 144 (Supplement 1): 3420.
https://doi.org/10.1182/blood-2024-207202
Published: 2024